[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY: PHARMACEUTICAL EXCIPIENTS MARKET

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS

4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE

5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ORGANIC CHEMICALS
5.3 INORGANIC CHEMICALS
5.4 OTHERS

6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
6.1 OVERVIEW
6.2 FILLERS AND DILUENTS
6.3 SUSPENDING AND VISCOSITY AGENTS
6.4 COATING AGENTS
6.5 BINDERS
6.6 DISINTEGRANTS
6.7 COLORANTS
6.8 LUBRICANTS AND GLIDANTS
6.9 PRESERVATIVES
6.10 EMULSIFYING AGENTS
6.11 FLAVORING AGENTS AND SWEETENERS
6.12 OTHER

7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATIONS
7.1 OVERVIEW
7.2 TOPICAL FORMULATIONS
7.3 ORAL FORMULATIONS
7.4 PARENTERAL FORMULATIONS
7.5 OTHER 

8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY END-USERS
8.1 OVERVIEW
8.2 PHARMACEUTICALS COMPANIES
8.3 RESEARCH ORGANIZATION
8.4 ACADEMICS
8.5 OTHERS

9 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 ONLINE PHARMACY
9.3 RETAIL
9.4 MAIL-ORDER 

10 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY GEOGRAPHY
10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO

10.3 EUROPE

10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3.1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA

10.6 SOUTH AMERICA

10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA

11 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES
11.4 COMPETITIVE DASHBOARD
11.5 PRODUCT MAPPING
11.6 TOP PLAYER POSITIONING, 2022
11.7 COMPETITIVE HEATMAP
11.8 TOP WINNING STRATEGIES

12 COMPANY PROFILES

12.1 ASHLAND GLOBAL HOLDINGS
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS
12.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.2 BASF SE
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS
12.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.3 DUPONT
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.4 ROQUETTE FERES
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.5 EVONIK INDUSTRIES AG
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.6 ASSOCIATED BRITISH FOODS
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.7 ARCHER DANIELS MIDLAND COMPANY
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS
12.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.8. LUBRIZOL CORPORATION
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS
12.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.9 CRODA INTERNATIONAL
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

12.10 KERRY GROUP
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS